Contact
Please use this form to send email to PR contact of this press release:
Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD
TO:
Please use this form to send email to PR contact of this press release:
Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD
TO: